Atlas Trials

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Clinical trial NCT05488431 · RECRUITING

Trial details

NCT number
NCT05488431
Sponsor
Priscilla Hsue, MD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DyslipidemiasCardiovascular DiseasesHIV InfectionsAtherosclerosis
Start date
2023-03-01
Primary completion
2028-03-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.